25P-NBOMe (2C-P-NBOMe, NBOMe-2C-P) is a derivative of the
phenethylamine 2C-P. It acts in a similar manner to related compounds such as
25I-NBOMe, which are potent
agonists at the
5HT2A receptor
Receptor may refer to:
* Sensory receptor, in physiology, any structure which, on receiving environmental stimuli, produces an informative nerve impulse
*Receptor (biochemistry), in biochemistry, a protein molecule that receives and responds to a ...
.
25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and
25C-NBOMe.
Legality
United Kingdom
See also
*
25E-NBOMe
25E-NBOMe (2C-E-NBOMe, NBOMe-2C-E) is a derivative of the phenethylamine 2C-E. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5HT2A receptor. 25E-NBOMe has been sold as a drug and produces ...
(NBOMe-2C-E)
*
25D-NBOMe
25D-NBOMe (or NBOMe-2C-D) is a derivative of the phenethylamine derived hallucinogen 2C-D. It acts in a similar manner to related compounds such as 25I-NBOMe, which is a potent agonist at the 5HT2A receptor. 25D-NBOMe has been sold as a street ...
(NBOMe-2C-D)
*
25I-NBOMe (NBOMe-2C-I)
*
25B-NBOMe (NBOMe-2C-B)
*
25C-NBOMe (NBOMe-2C-C)
*
25TFM-NBOMe
25TFM-NBOMe (also known as NBOMe-2C-TFM, 2C-TFM-NBOMe, and Cimbi-138) is a derivative of the phenethylamine hallucinogen 2C-TFM, discovered in 2004 by Ralf Heim at the Free University of Berlin. It acts as a potent partial agonist for the 5HT2A ...
(NBOMe-2C-TFM)
*
25T7-NBOMe
25T7-NBOMe (also known as 2C-T-7-NBOMe or NBOMe-2C-T-7), is a substituted phenethylamine derivative from the 25-NB family. It acts as an agonist at the 5-HT2A and 5-HT2C serotonin receptors, has psychedelic effects and has been sold as a design ...
(NBOMe-2C-T-7)
References
25-NB (psychedelics)
Designer drugs
{{hallucinogen-stub